Commercialization Reactor
Overview
Commercialization Reactor is an international deep-tech commercialization platform and venture fund that creates, accelerates, and invests in deep-tech and science-based startups.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Sepsiscan | Jan 2024 | Convertible Debt | Co-investor |
| Elogium Probiotics | Feb 2023 | Seed | Co-investor |
| NanoWired GmbH | Jan 2018 | Seed | Co-investor |
| Empyrio | Dec 2022 | Seed | Co-investor |
| Sizzapp | Mar 2019 | Pre Seed | Lead |
Key People
Nikolai Adamovitch
Founder And CEO
Toms Aboltins
Investor
Evija Vascenko
Venture Entrepreneurial Partner
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Commercialization Reactor based?
Commercialization Reactor is headquartered in Riga, Latvia.
When was Commercialization Reactor founded?
Commercialization Reactor was founded in 2009.
How many portfolio companies does Commercialization Reactor have?
Commercialization Reactor has 5 portfolio companies in Caplight's dataset.
What are some companies in Commercialization Reactor's portfolio?
Portfolio companies visible on Caplight include Sepsiscan, Elogium Probiotics, NanoWired GmbH, Empyrio, Sizzapp.
What was Commercialization Reactor's most recent investment shown here?
Commercialization Reactor's most recent investment in this portfolio sample was in Sepsiscan in 2024.
What sectors does Commercialization Reactor focus on?
Commercialization Reactor focuses on Mobility, Transportation & Logistics, Frontier & Industrial Tech, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, Energy & Sustainability, Frontier & Industrial Tech, Frontier & Industrial Tech, Energy & Sustainability, Consumer & Commerce.
What company stages does Commercialization Reactor focus on?
Commercialization Reactor typically invests at the Early stage.